Status:
RECRUITING
Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected in...
Detailed Description
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. Current practice and my experience in diabetes show a misu...
Eligibility Criteria
Inclusion
- Older than 18 years patient with type 1 or 2 diabetes
- Treated with multiple insulin injections
- Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before
- Dependent on a health professional for treatment management.
- Subject informed of the study and not objecting to data collection.
Exclusion
- \- Patient refusing study.
Key Trial Info
Start Date :
March 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06192940
Start Date
March 28 2024
End Date
December 31 2025
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France, 91106